sterling pharma limited
sterling pharma limited Company Information
Company Number
11930365
Next Accounts
Jan 2026
Shareholders
mohammed ikhlaq
mohammed adam issat
View AllGroup Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
richmond house canal road, bradford, west yorkshire, BD2 1AL
sterling pharma limited Estimated Valuation
Pomanda estimates the enterprise value of STERLING PHARMA LIMITED at £66.1k based on a Turnover of £149.9k and 0.44x industry multiple (adjusted for size and gross margin).
sterling pharma limited Estimated Valuation
Pomanda estimates the enterprise value of STERLING PHARMA LIMITED at £25.6k based on an EBITDA of £5.8k and a 4.45x industry multiple (adjusted for size and gross margin).
sterling pharma limited Estimated Valuation
Pomanda estimates the enterprise value of STERLING PHARMA LIMITED at £0 based on Net Assets of £-12.8k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sterling Pharma Limited Overview
Sterling Pharma Limited is a live company located in west yorkshire, BD2 1AL with a Companies House number of 11930365. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 2019, it's largest shareholder is mohammed ikhlaq with a 25% stake. Sterling Pharma Limited is a young, micro sized company, Pomanda has estimated its turnover at £149.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Sterling Pharma Limited Health Check
Pomanda's financial health check has awarded Sterling Pharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
6 Weak
Size
annual sales of £149.9k, make it smaller than the average company (£25.2m)
- Sterling Pharma Limited
£25.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (5.6%)
- Sterling Pharma Limited
5.6% - Industry AVG
Production
with a gross margin of 27.2%, this company has a comparable cost of product (27.2%)
- Sterling Pharma Limited
27.2% - Industry AVG
Profitability
an operating margin of 3.3% make it as profitable than the average company (3.7%)
- Sterling Pharma Limited
3.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
1 - Sterling Pharma Limited
36 - Industry AVG
Pay Structure
on an average salary of £77.3k, the company has an equivalent pay structure (£77.3k)
- Sterling Pharma Limited
£77.3k - Industry AVG
Efficiency
resulting in sales per employee of £149.9k, this is less efficient (£674.5k)
- Sterling Pharma Limited
£674.5k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (59 days)
- Sterling Pharma Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (30 days)
- Sterling Pharma Limited
30 days - Industry AVG
Stock Days
it holds stock equivalent to 17 days, this is less than average (62 days)
- Sterling Pharma Limited
62 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 28 weeks, this is more cash available to meet short term requirements (12 weeks)
28 weeks - Sterling Pharma Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 137.3%, this is a higher level of debt than the average (53.8%)
137.3% - Sterling Pharma Limited
53.8% - Industry AVG
STERLING PHARMA LIMITED financials
Sterling Pharma Limited's latest turnover from April 2024 is estimated at £149.9 thousand and the company has net assets of -£12.8 thousand. According to their latest financial statements, Sterling Pharma Limited has 1 employee and maintains cash reserves of £26.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | |
|---|---|---|---|---|---|
| Tangible Assets | 1,322 | 2,102 | 1,799 | 2,398 | |
| Intangible Assets | |||||
| Investments & Other | |||||
| Debtors (Due After 1 year) | 849 | 71 | |||
| Total Fixed Assets | 2,171 | 2,102 | 1,799 | 2,469 | |
| Stock & work in progress | 5,227 | 11,303 | 23,835 | 8,785 | |
| Trade Debtors | 791 | 262 | 262 | 817 | |
| Group Debtors | |||||
| Misc Debtors | 17 | ||||
| Cash | 26,069 | 19,205 | 6,308 | 10,632 | 100 |
| misc current assets | |||||
| total current assets | 32,087 | 30,770 | 30,422 | 20,234 | 100 |
| total assets | 34,258 | 32,872 | 32,221 | 22,703 | 100 |
| Bank overdraft | |||||
| Bank loan | |||||
| Trade Creditors | 60 | 3,993 | |||
| Group/Directors Accounts | 13,419 | 13,423 | 14,051 | 4,827 | |
| other short term finances | |||||
| hp & lease commitments | |||||
| other current liabilities | 33,550 | 32,851 | 33,550 | 32,775 | |
| total current liabilities | 47,029 | 50,267 | 47,601 | 37,602 | |
| loans | |||||
| hp & lease commitments | |||||
| Accruals and Deferred Income | |||||
| other liabilities | |||||
| provisions | |||||
| total long term liabilities | |||||
| total liabilities | 47,029 | 50,267 | 47,601 | 37,602 | |
| net assets | -12,771 | -17,395 | -15,380 | -14,899 | 100 |
| total shareholders funds | -12,771 | -17,395 | -15,380 | -14,899 | 100 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 780 | 825 | 599 | 599 | |
| Amortisation | |||||
| Tax | |||||
| Stock | -6,076 | -12,532 | 15,050 | 8,785 | |
| Debtors | 1,378 | -17 | -609 | 888 | |
| Creditors | -3,933 | 3,993 | |||
| Accruals and Deferred Income | 699 | -699 | 775 | 32,775 | |
| Deferred Taxes & Provisions | |||||
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | |||||
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | |||||
| Group/Directors Accounts | -4 | -628 | 9,224 | 4,827 | |
| Other Short Term Loans | |||||
| Long term loans | |||||
| Hire Purchase and Lease Commitments | |||||
| other long term liabilities | |||||
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 6,864 | 12,897 | -4,324 | 10,532 | 100 |
| overdraft | |||||
| change in cash | 6,864 | 12,897 | -4,324 | 10,532 | 100 |
sterling pharma limited Credit Report and Business Information
Sterling Pharma Limited Competitor Analysis
Perform a competitor analysis for sterling pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in BD2 area or any other competitors across 12 key performance metrics.
sterling pharma limited Ownership
STERLING PHARMA LIMITED group structure
Sterling Pharma Limited has no subsidiary companies.
Ultimate parent company
STERLING PHARMA LIMITED
11930365
sterling pharma limited directors
Sterling Pharma Limited currently has 4 directors. The longest serving directors include Mr Asif Mahmood (Apr 2019) and Mr Mohammed Ikhlaq (Apr 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Asif Mahmood | United Kingdom | 51 years | Apr 2019 | - | Director |
| Mr Mohammed Ikhlaq | England | 55 years | Apr 2019 | - | Director |
| Mr Mohammed Issat | England | 49 years | Apr 2019 | - | Director |
| Mr Mohammed Eshak | 57 years | Apr 2019 | - | Director |
P&L
April 2024turnover
149.9k
-6%
operating profit
5k
0%
gross margin
27.2%
+1.31%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
-12.8k
-0.27%
total assets
34.3k
+0.04%
cash
26.1k
+0.36%
net assets
Total assets minus all liabilities
Similar Companies
sterling pharma limited company details
company number
11930365
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 2019
age
6
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
richmond house canal road, bradford, west yorkshire, BD2 1AL
Bank
-
Legal Advisor
-
sterling pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to sterling pharma limited.
sterling pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for STERLING PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
sterling pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
